European Economic AreaNorthern IrelandREACH

New Report Claims Corporate Lobbying Threatens EU PFAS Restrictions

A new report reveals extensive corporate lobbying against the EU's proposed PFAS restrictions. The investigation highlights industry tactics to delay the process and calls for increased transparency and reform to protect public interest from corporate influence.

Published in January 2025. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

3 min readAI-drafted, expert reviewed

Chemical Reaction Report: Inside the corporate fight against the EU's PFAS restriction - by CEO

A recent report by the Corporate Europe Observatory (CEO) alleges that corporate lobbying efforts are undermining the European Union's proposed restrictions on PFAS, known as 'forever chemicals'. Released in January 2025, the report claims that industry giants are exerting significant pressure to delay or weaken these crucial regulations.

Allegations Of Intense Lobbying Efforts

The CEO report, based on over 14,000 previously unpublished documents, suggests that major chemical producers, including Chemours, DuPont, and 3M, are actively lobbying against the EU's proposed restrictions on PFAS. These chemicals, used in products such as non-stick cookware, waterproof clothing, and firefighting foams, are under scrutiny due to their persistence in the environment and potential health risks. The report claims that industry lobbyists have inundated the EU with responses, allegedly causing significant delays in the consultation process. However, it is important to approach these claims with caution, as they reflect the CEO's perspective and may not encompass the full complexity of the issue.

The Role And Risks Of PFAS In Manufacturing

PFAS are highly valued in industrial applications for their durability and resistance to heat and chemicals. These properties make them indispensable in manufacturing processes across various sectors, including electronics, automotive, and textiles. Despite their benefits, PFAS have been linked to serious environmental and health concerns. Their persistence in the environment means they do not break down easily, leading to accumulation in water, soil, and even human bodies. Health risks associated with PFAS exposure include cancer, liver damage, and hormone disruption. In response to these concerns, the EU has proposed a universal restriction on PFAS, aiming to phase out their use unless deemed essential for society.

Industry's Response And Lobbying Tactics

The report highlights several tactics allegedly employed by industry lobbyists to influence the EU's decision-making process. These include commissioning impact assessments to highlight potential economic consequences of the ban and mobilising allies to amplify their message. The CEO claims that industry-funded studies often exaggerate the economic impact of the proposed restrictions while downplaying the environmental and health benefits. For instance, Chemours has reportedly increased its lobbying expenditure and engaged law firms to challenge the legal basis of the restrictions. Additionally, industry groups like CEFIC and Plastics Europe are said to be actively involved in lobbying efforts. However, these assertions should be viewed with scepticism, as they represent the CEO's viewpoint and may not fully capture the industry's perspective.

Calls For Greater Transparency And Reform

In light of these allegations, the CEO report calls for increased transparency in the EU's decision-making process. It advocates for the implementation of a legally binding lobby transparency register to ensure that all lobbying activities are publicly disclosed. Additionally, the report recommends halting private meetings between the European Commission and industry lobbyists seeking exemptions. These recommendations aim to safeguard the integrity of the regulatory process and ensure that public health and environmental concerns are prioritised.

Official source

corporateeurope.org

Topics

Questions about this change

What are PFAS and why are they controversial?

PFAS, or 'forever chemicals', are synthetic substances used in various products for their resistance to heat and water. They are controversial due to their persistence in the environment and potential health risks, including cancer and liver damage, prompting calls for regulation.

How is the EU addressing PFAS risks?

The EU is proposing a universal restriction on PFAS to phase out their use unless deemed essential. This initiative aims to mitigate environmental and health risks but faces significant opposition from industry lobbyists seeking exemptions.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX